BL
JNJ icon

Balentine LLC’s Johnson & Johnson JNJ Stock Holding History

Balentine LLC’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
9,720
+3,558
+58% +$829K 0.1% 48
2025
Q4 		$1.28M Sell
6,162
-312
-5% -$61.7K 0.05% 69
2025
Q3 		$1.2M Buy
6,474
+1,907
+42% +$327K 0.04% 71
2025
Q2 		$698K Sell
4,567
-266
-6% -$40.9K 0.03% 85
2025
Q1 		$801K Sell
4,833
-799
-14% -$125K 0.03% 82
2024
Q4 		$815K Sell
5,632
-2,116
-27% -$328K 0.03% 64
2024
Q3 		$1.26M Buy
7,748
+3,345
+76% +$533K 0.05% 58
2024
Q2 		$644K Sell
4,403
-36,282
-89% -$5.4M 0.03% 68
2024
Q1 		$6.44M Sell
40,685
-43,057
-51% -$6.85M 0.19% 48
2023
Q4 		$13.1M Buy
83,742
+224
+0.3% +$34.3K 0.42% 21
2023
Q3 		$13M Buy
83,518
+1,775
+2% +$293K 0.43% 20
2023
Q2 		$13.5M Sell
81,743
-9,800
-11% -$1.58M 0.45% 18
2023
Q1 		$14.2M Sell
91,543
-30,600
-25% -$4.94M 0.48% 21
2022
Q4 		$21.6M Buy
122,143
+17,090
+16% +$2.95M 0.75% 14
2022
Q3 		$17.2M Sell
105,053
-25,237
-19% -$4.27M 0.65% 17
2022
Q2 		$23.1M Buy
130,290
+64,928
+99% +$11.6M 0.85% 14
2022
Q1 		$11.6M Buy
65,362
+34,414
+111% +$5.86M 0.39% 17
2021
Q4 		$5.29M Buy
30,948
+8,585
+38% +$1.41M 0.19% 24
2021
Q3 		$3.61M Buy
22,363
+11,325
+103% +$1.93M 0.14% 23
2021
Q2 		$1.82M Buy
11,038
+3,165
+40% +$524K 0.07% 29
2021
Q1 		$1.29M Buy
7,873
+1,529
+24% +$247K 0.06% 33
2020
Q4 		$999K Buy
6,344
+1,900
+43% +$280K 0.05% 36
2020
Q3 		$662K Buy
4,444
+1,815
+69% +$269K 0.03% 44
2020
Q2 		$370K Sell
2,629
-668
-20% -$97.3K 0.02% 49
2020
Q1 		$432K Buy
3,297
+1,473
+81% +$209K 0.03% 33
2019
Q4 		$266K Buy
1,824
+396
+28% +$53.7K 0.02% 57
2019
Q3 		$185K Buy
1,428
+793
+125% +$104K 0.01% 65
2019
Q2 		$88K Sell
635
-617
-49% -$85.4K 0.01% 75
2019
Q1 		$175K Sell
1,252
-17
-1% -$2.28K 0.01% 61
2018
Q4 		$164K Buy
1,269
+900
+244% +$126K 0.01% 64
2018
Q3 		$51K Buy
369
+299
+427% +$39.7K ﹤0.01% 69
2018
Q2 		$8K Hold
70
– – ﹤0.01% 107
2018
Q1 		$9K Sell
70
-3,324
-98% -$449K ﹤0.01% 38
2017
Q4 		$474K Hold
3,394
– – 0.04% 68
2017
Q3 		$441K Buy
3,394
+851
+33% +$113K 0.04% 66
2017
Q2 		$336K Buy
2,543
+179
+8% +$22.8K 0.03% 79
2017
Q1 		$294K Sell
2,364
-10
-0.4% -$1.2K 0.03% 76
2016
Q4 		$274K Sell
2,374
-13
-0.5% -$1.5K 0.03% 80
2016
Q3 		$282K Sell
2,387
-239
-9% -$29K 0.04% 73
2016
Q2 		$319K Buy
2,626
+196
+8% +$22.3K 0.06% 51
2016
Q1 		$263K Sell
2,430
-30
-1% -$3.11K 0.07% 44
2015
Q4 		$253K Sell
2,460
-83
-3% -$8.35K 0.05% 59
2015
Q3 		$237K Buy
2,543
+102
+4% +$9.87K 0.04% 59
2015
Q2 		$238K Hold
2,441
– – 0.04% 43
2015
Q1 		$246K Buy
+2,441
New +$248K 0.05% 40

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Balentine LLC's JNJ Position: Q1 2026 in Review

Balentine LLC increased its Johnson & Johnson (JNJ) stake by 58% in Q1 2026, buying an estimated $829K and bringing the position to 9,720 shares worth $2.38M. The position accounts for 0.1% of the portfolio, ranked #48.

Balentine LLC first reported a position in JNJ in Q1 2015 and has held it in 45 quarters since. The position peaked at $23.1M in Q2 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Balentine LLC held 9,720 shares of Johnson & Johnson worth $2.38M as of Q1 2026.
  • Balentine LLC bought 3,558 Johnson & Johnson shares in Q1 2026, an estimated $829K.
  • Johnson & Johnson made up 0.1% of Balentine LLC's portfolio in Q1 2026, its #48 holding.
  • Balentine LLC first reported a position in Johnson & Johnson in Q1 2015 and has held it in 45 quarters since.
  • Balentine LLC's Johnson & Johnson position peaked at $23.1M in Q2 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Balentine LLC's 13F filing for Q1 2026, filed 24 Apr 2026.